Anton Bilchik

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling
    Hiroya Takeuchi
    Department of Molecular Oncology, Gastrointestinal Section, Santa Monica, CA 90404, USA
    Clin Cancer Res 11:7621-8. 2005
  2. doi request reprint Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials
    Anton Bilchik
    California Oncology Research Institute, University of California, Los Angeles, CA 90404, USA
    Ann Surg 252:467-74; discussion 474-6. 2010
  3. doi request reprint Adjuvant treatment of early colon cancer with micrometastases: results of a national survey
    Scott S Short
    Cedars Sinai Medical Center, Los Angeles, California, USA
    J Surg Oncol 106:119-22. 2012
  4. ncbi request reprint The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis
    Douglas Iddings
    Department of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA 90404, USA
    Ann Surg Oncol 13:1386-92. 2006
  5. ncbi request reprint Association of angiogenesis markers with lymph node metastasis in early colorectal cancer
    Douglas M Iddings
    Department of Surgical Oncology, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
    Arch Surg 142:738-44; discussion 744-5. 2007
  6. doi request reprint Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence
    Michiel F G de Maat
    Department of Molecular Oncology, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
    J Clin Oncol 26:2327-35. 2008
  7. doi request reprint Lymph node ratio as a quality and prognostic indicator in stage III colon cancer
    Steven L Chen
    Department of Surgery, University of California, Davis, CA, USA
    Ann Surg 253:82-7. 2011

Research Grants

  1. Ultrastaging of Early Colon Cancer
    Anton Bilchik; Fiscal Year: 2009
  2. Lymphatic Mapping and Sentinel Node ANALYSIS
    Anton Bilchik; Fiscal Year: 2001
  3. Lymphatic Mapping and Sentinel Node ANALYSIS
    Anton Bilchik; Fiscal Year: 2002
  4. Lymphatic Mapping and Sentinel Node ANALYSIS
    Anton Bilchik; Fiscal Year: 2003
  5. Lymphatic Mapping and Sentinel Node ANALYSIS
    Anton Bilchik; Fiscal Year: 2004
  6. Ultrastaging of Early Colon Cancer
    Anton J Bilchik; Fiscal Year: 2010

Collaborators

Detail Information

Publications7

  1. ncbi request reprint X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling
    Hiroya Takeuchi
    Department of Molecular Oncology, Gastrointestinal Section, Santa Monica, CA 90404, USA
    Clin Cancer Res 11:7621-8. 2005
    ..We hypothesized that the hepatocyte growth factor (HGF) activation in colorectal cancer via c-Met receptor regulates IAP proteins through Akt signaling...
  2. doi request reprint Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials
    Anton Bilchik
    California Oncology Research Institute, University of California, Los Angeles, CA 90404, USA
    Ann Surg 252:467-74; discussion 474-6. 2010
    ..The prognostic value of ultrastaging hematoxylin and eosin (H&E) negative LNs (N0) using pan-cytokeratin immunohistochemistry (pan-CK-IHC) is unknown...
  3. doi request reprint Adjuvant treatment of early colon cancer with micrometastases: results of a national survey
    Scott S Short
    Cedars Sinai Medical Center, Los Angeles, California, USA
    J Surg Oncol 106:119-22. 2012
    ..Optimal adjuvant treatment for patients with Stage I/II colon cancer with micrometastases (MM) is unknown. Because there is no known adjuvant treatment-related benefit, we evaluated whether MM influenced treatment decisions...
  4. ncbi request reprint The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis
    Douglas Iddings
    Department of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA 90404, USA
    Ann Surg Oncol 13:1386-92. 2006
    ..To determine the prognostic significance of micrometastases in colorectal cancer, a meta-analysis was performed on all studies, which reported 3-year disease-free survival (DFS) and overall survival (OS)...
  5. ncbi request reprint Association of angiogenesis markers with lymph node metastasis in early colorectal cancer
    Douglas M Iddings
    Department of Surgical Oncology, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
    Arch Surg 142:738-44; discussion 744-5. 2007
    ..We hypothesized that p53 mutations (mp53) are associated with decreased expression of thrombospondin 1 (TSP-1) and that decreased TSP-1 expression is associated with lymph node metastases...
  6. doi request reprint Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence
    Michiel F G de Maat
    Department of Molecular Oncology, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA
    J Clin Oncol 26:2327-35. 2008
    ..We then explored in a different clinical patient group whether these epigenetic changes could be correlated with clinical outcome...
  7. doi request reprint Lymph node ratio as a quality and prognostic indicator in stage III colon cancer
    Steven L Chen
    Department of Surgery, University of California, Davis, CA, USA
    Ann Surg 253:82-7. 2011
    ..Similarly, the number of resected/evaluated nodes impacts staging accuracy. This ratio of metastatic to examined nodes or lymph node ratio (LNR) may have independent prognostic value in colon carcinoma...

Research Grants6

  1. Ultrastaging of Early Colon Cancer
    Anton Bilchik; Fiscal Year: 2009
    ....
  2. Lymphatic Mapping and Sentinel Node ANALYSIS
    Anton Bilchik; Fiscal Year: 2001
    ..This proposed approach may ultimately improve the selection of patients for adjuvant therapy following resection of early-stage colon cancer. ..
  3. Lymphatic Mapping and Sentinel Node ANALYSIS
    Anton Bilchik; Fiscal Year: 2002
    ..This proposed approach may ultimately improve the selection of patients for adjuvant therapy following resection of early-stage colon cancer. ..
  4. Lymphatic Mapping and Sentinel Node ANALYSIS
    Anton Bilchik; Fiscal Year: 2003
    ..This proposed approach may ultimately improve the selection of patients for adjuvant therapy following resection of early-stage colon cancer. ..
  5. Lymphatic Mapping and Sentinel Node ANALYSIS
    Anton Bilchik; Fiscal Year: 2004
    ..This proposed approach may ultimately improve the selection of patients for adjuvant therapy following resection of early-stage colon cancer. ..
  6. Ultrastaging of Early Colon Cancer
    Anton J Bilchik; Fiscal Year: 2010
    ....